|
|
|
|
|
searchin this issue 
premium serviceseventsdirectory servicesadvertisingcustomer care |
Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Displaying 141 - 160 of 876 stories.
October 9, 2012
The US FDA did a good job of implementing the Generic Drug User Fee Act (GDUFA), but has disappointed as far as the falsified medicines directive (FMD) of the European Union (EU) is...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/EFCG-at-CPhI-FDA-did-well-to-implement-GDUFA-but-disappoints-with-FMD-_46844.html October 9, 2012
Tessenderlo Group said today that it intends to sell its pharmaceutical ingredients activities Farchemia and Calaire Chimie to International Chemical Investors Group (ICIG; Frankfurt)...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Tessenderlo-Group-sells-pharma-ingredients-business-to-International-Chemical-Investors_46813.html October 4, 2012
Sigma-Aldrich Fine Chemicals (SAFC; St. Louis, MO), a life science company, plans to expand its Scotland operations with the development of a new powder manufacturing facility at its...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Sigma-Aldrich-Begins-Construction-of-Powder-Manufacturing-Facility-at-U-K-Site_46581.html October 3, 2012
Pharmaceutical company Daiichi Sankyo (Tokyo) says it has decided to reorganize three of its supply chain subsidiaries in Japan – Daiichi Sankyo Propharma (DSPP; Tokyo), Daiichi...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Daiichi-Sankyo-to-restructure-pharma-ingredient-subsidiaries_46639.html October 3, 2012
Cedarburg Hauser Pharmaceuticals (CHP; Grafton, WI) says it has expanded the capacity of its active pharmaceutical ingredient (API) manufacturing plant in Wisconsin. CHP is a contract...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cedarburg-Hauser-Expands-API-Production-Capacity_46548.html October 3, 2012
BASF says it will relocate the global headquarters of the pharma ingredients and services business unit from Evionnaz, Switzerland, to Florham Park, NJ. The company has also...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/BASF-to-move-pharma-ingredients-headquarters-to-US-appoints-new-business-head_46597.html October 2, 2012
BASF to move pharma ingredients headquarters to US, appoints new business head BASF says it will relocate the global headquarters of the pharma ingredients and services business unit...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-October-2_46641.html October 2, 2012
Mitsubishi Gas Chemical (MGC) says it will stop the manufacture and sale of coenzyme Q10, a material for pharmaceuticals and health food, due to poor profitability of the business...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mitsubishi-Gas-Chemical-exits-coenzyme-Q10-business_46634.html October 1, 2012
Ashland says it will open a new pharmaceutical application laboratory at Düsseldorf in December 2012. The laboratory will provide technical support to Ashland’s European...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ashland-to-open-pharmaceutical-lab-in-Germany_46593.html September 27, 2012
The European Commission has made two proposals to close loopholes in current European Union (EU) legislation on precursors for the illegal drugs methamphetamine and heroin. The...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/EU-Commission-Proposes-Tighter-Controls-on-Precursors-for-Illegal-Drugs_46550.html September 27, 2012
Lonza says that biopharmaceutical company Intellect Neurosciences (New York) has awarded the future development and manufacture of the antibody-drug conjugate Conjumab-A to Lonza...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-to-Develop-Manufacture-U-S-Biopharma-Firms-Antibody-Drug-Conjugate_46545.html September 25, 2012
FINE CHEMICALS: STAYING ACTIVE The global active pharmaceutical ingredient (API) industry is very competitive, and manufacturers are faced with several challenges, including pricing...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-September-25_46501.html September 25, 2012
Carbogen Amcis (Bubendorf, Switzerland), a pharma process-development and active pharmaceutical ingredient (API) manufacturing subsidiary of Dishman Pharmaceuticals and Chemicals...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Carbogen-Amcis-Partners-with-ADC-Biotechnology_46499.html September 25, 2012
The manufacture of active pharmaceutical ingredients (APIs) will account for the majority of revenues in the pharmaceutical contract manufacturing industry in the next 10 years, says a...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/APIs-Will-Drive-Growth-in-Contract-Manufacturing_46498.html September 18, 2012
IMCD ACQUIRES PHARMA INGREDIENTS DISTRIBUTOR IN MALAYSIA Distributor IMCD Group (Rotterdam), says it has acquired the pharmaceutical ingredients distribution business of Maxwell Pharma...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-September-18_46331.html September 18, 2012
Distributor IMCD Group (Rotterdam) says it has acquired the pharmaceutical ingredients distribution business of Maxwell Pharma (Petaling Jaya, Malaysia), a privately owned company...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/IMCD-Acquires-Pharma-Ingredients-Distributor-in-Malaysia_46330.html September 11, 2012
CAMBRIDGE MAJOR EXPANDS API FACILITY Cambridge Major Laboratories (CML; Germantown, WI) says it has significantly expanded its active pharmaceutical ingredient (API) manufacturing...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-September-11_46167.html September 11, 2012
Unipex Group (Paris) says its current owner, AXA Private Equity (Paris), has reached an agreement to sell 100% of its interest in Unipex, to the IK2007 Fund, advised by private equity...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Unipex-Group-Changes-Private-Equity-Hands_46162.html September 10, 2012
Cambridge Major Laboratories (CML; Germantown, WI) says it has significantly expanded its active pharmaceutical ingredient (API) manufacturing facility at Germantown, following...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambridge-Major-Expands-API-Facility_46130.html September 4, 2012
HOSPIRA TO ACQUIRE API FACILITY IN INDIA FOR $200 MILLION Hospira (Lake Forest, IL), the world's leading provider of injectable drugs and infusion technologies, says it has signed an...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-September-4_46013.html |
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|
Follow us on Twitter
